Spots Global Cancer Trial Database for Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
Official Title: Prospective Noninterventional Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Tumours (GEP-NETs) in Routine Clinical Practice
Study ID: NCT03895463
Conditions
Interventions
Study Description
Brief Summary: The main aim of this study is to assess the Progression-Free Survival (PFS) at 12 months of Lanreotide Autogel 120 mg use when administered as part of routine GEP-NET treatment and to follow patient treatment pathways, identify prognostic factors of PFS, evaluate patient's QoL, and patient's and clinician's satisfaction with treatment in routine long-term care setting. The study will provide real-world evidence on the use of Lanreotide Autogel 120 mg and will provide information on topics such as optimization of product usage and identification of best practices and will provide evidence on product effectiveness in a realistic setting.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Uniwersyteckie Centrum Kliniczne, Gdańsk, , Poland
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Oddział w Gliwicach, Gliwice, , Poland
Uniwersyteckie Centrum Kliniczne im. Prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego w Katowicach, Katowice, , Poland
Świętokrzyskie Centrum Onkologii, Kielce, , Poland
Szpital Uniwersytecki w Krakowie, Kraków, , Poland
Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Medycznego w Poznaniu, Poznań, , Poland
Samodzielny Publiczny Szpital Kliniczny Nr 1 Pomorskiego Uniwersytetu Medycznego im. prof. Tadeusza Sokołowskiego, Szczecin, , Poland
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw, , Poland
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Centralny Szpital Kliniczny, Warsaw, , Poland
Dolnośląskie Centrum Onkologii we Wrocławiu, Wrocław, , Poland
SPZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi, Łódź, , Poland
Contact Details
Name: Ipsen Medical Director
Affiliation: Ipsen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
